DEADLINE: 11TH OCTOBER, 2021
NATIONAL OBSTETRIC FISTULA CENTRE (NOFIC) NINGI
INVITATION TO TENDER

(1) INTRODUCTION:
(1.1) The National Obstetric Fistula Centre Ningi, a Specialized Tertiary Health Institution located along Kano Road Ningi, Bauchi State wishes to execute projects under Covid-19 Intervention Programme.

(1.2) The Centre therefore, invites experience and competent contractors/suppliers to submit Technical & Financial bids for Emergency Procurement of the under listed projects.

(2) SCOPE OF WORKS

LOT NOsDESCRIPTION
T1Construction of Molecular Laboratory
T2Procurement and Installation of Molecular Laboratory Equipment

(3) ELIGIBILITY REQUIREMENTS
Prospective Bidders must possess all the under-listed requirements to be eligible to participate in this procurement:-

(a)  Evidence of Certificate of Incorporation issued by the Corporate Affairs Commission (CAC) including Form CAC 1.1 or CAC2 and CAC7;

(b) Evidence of Company’s Income Tax Clearance Certificate for the last three (3) Years (2018, 2019 & 2020) valid till 31st December, 2021;

(c )  Evidence of Pension Clearance Certificate valid till 31st December, 2021 (applicable where number of staff is at least 15);

(d) Evidence of Industrial Training Fund (ITF) Compliance Certificate valid till 31st December, 2021 (applicable where number of staff is at least 5 or at least N50m turnover);

(e ) Evidence of Nigeria Social Insurance Trust Fund (NSITF) Clearance Certificate valid till 31st December, 2021;

(f) Evidence of Registration on the National Database of Federal Contractors, Consultants and Service Providers by Submission of Interim Registration Report (IRR) expiring on 31/12/2021 or valid Certificate Issued by BPP;

(g) Sworn Affidavit:

  • Disclosing whether or not any officer of the relevant committees of the National Obstetric Fistula Centre Ningi or the Bureau of Public Procurement is a former or present Director, Shareholder or has any pecuniary interest in the bidder and to confirm that all information presented in its bid are true and correct in all particulars
  • that the Company is not in receivership, insolvent or bankruptcy;
  • None of the Directors of the company has been convicted in any court for any criminal offence including fraud and financial impropriety;

(h) Company’s Audited Accounts for the Last Three (3) Years 2018, 2019 & 2020;

(i) Reference Letter from a refutable commercial bank in Nigeria, indicating willingness to provide credit facility for the execution of the project when needed;

(j) Company’s Profile with the Curriculum Vitae of Key Staff to be deployed for the project, including copies of their Academic/Professional Qualifications;

(k) Verifiable documentary evidence:

(i) Lot 1: at least Three (3) Similar Jobs successfully Executed projects in the Last Five (5) Years Including Letters of Awards, Valuation Certificates, Job Completion Certificates and Photographs of the Projects;

(ii) Lot 2: at least One (1) Similar Molecular Equipping jobs successfully executed in the Last Two (2) Years Including Letters of Awards, Valuation Certificates, Job Completion Certificates and Photographs of the Projects;

(l) Lot 1: List of Plants/Equipment with proof of Ownership/Lease;

(m) Company’s Profile with the Curriculum Vitae of Key Staff to be deployed for the project, including at least Three (3) trained Original Equipment manufacturers (OEM) Biomedical Engineers;

(n) Lot 2: Letter of Authorization from the Original Equipment Manufacturers (OEMs) listed in the Approved policy for procurement for Health and Medical Equipment for Tertiary Hospitals in Nigeria, published by the BPP/FMOH/SON/NNRA, year 2017-2018 (2nd Revision);

(o) For Joint Venture/Partnership, Memorandum of Understanding (MoU) should be provided (CAC, Tax Clearance Certificate, Pension Clearance Certificate, ITF Compliance Certificate, NSITF Clearance Certificate, IRR & Sworn Affidavit are compulsory for each JV partner).

(p) All documents for submission must be transmitted with a Covering/Forwarding Letter under the Company/Firm’s Letter Head Paper bearing amongst others, the Registration Number (RC) as issued by the Corporate Affairs Commission (CAC), Contact Address, Telephone Number (Preferably GSM No.), and e-mail address. The Letter Head Paper must bear the Names and Nationalities of the Directors of the Company at the Bottom of the page, duly signed by the authorized officer of the firm.

(4) COLLECTION OF TENDER DOCUMENTS
Tender documents can be obtained from the Office of the SECRETARY TENDERS BOARD, NATIONAL OBSTETRIC FISTULA CENTRE, NINGI after payment of non-refundable tender fees of N10, 000.00 for each Lot, into National Obstetric Fistula Centre Ningi’s Remita Account in any reputable commercial bank in Nigeria.

(5) SUBMISSION OF TENDER DOCUMENT
All Completed Technical and Financial Tender shall be submitted in Two (2) hard copies and One (1) Soft copy (flash drive) in Two (2) separate sealed envelopes, clearly marked “Technical Bid” for Lot … and Financial Bid for Lot—- (Indicate the Lot Number) which shall be inserted in a bigger third sealed envelope, and addressed to the Medical Director, NOFIC, Ningi, Bauchi State. The projects title, lot number and contractor’s name must be clearly written on top of each envelope, which must be dropped in the Tender Box located at the Office of The Head of Administration of the Hospital not later than 12:00 noon on Monday 11 October, 2021.

(6) OPENING OF TECHNICAL BIDS
Only the Technical bids will be opened immediately after the deadline for submission at 12:00 noon on Monday 11 October, 2021 at the Conference Hall (Surgical Ward).

(7) GENERAL INFORMATION
(a) Bids must be in English Language and signed by an official authorised by the bidder;

(b) Bids submitted after the deadline for submission would be returned un-opened;

(c) Bidders are advised to read this solicitation carefully, any submissions that do not meet up with any of the requirements specified above shall be rejected;

(d) Bidders should not bid for more than one (1) Lot.

(e) All costs will be borne by the bidders;

(f) All documents submitted may be referred to the respective issuing authority for verification and authentication.

(g) Presence of bidders/representatives and members of the public shall not be required during the bid opening ceremony in compliance with COVID-19 Guidelines. The Bids Opening will be covered by video recording (link will be sent to bidders) with the presence of two (2) representatives of private sector professional bodies and Civil Society Organisation in the areas of Anti-Corruption/Transparency;

(h) Bid documents can be can also be collected in soft copies and Bidders can submit through post (Courier Services);

(i) The National Obstetric Fistula Centre Ningi is not bound to pre-qualify any bidder and reserves the right to annul the Procurement process at any time without incurring any liabilities in accordance with Section 28 of the Public Procurement Act, 2007.

SIGNED
MEDICAL DIRECTOR
NATIONAL OBSTETRIC FISTULA CENTRE NINGI